ADENOSINE RECEPTORS IN RAT BASOPHILIC LEUKEMIA-CELLS - TRANSDUCTIONAL MECHANISMS AND EFFECTS ON 5-HYDROXYTRYPTAMINE RELEASE

被引:11
作者
ABBRACCHIO, MP
PAOLETTI, AM
LUINI, A
CATTABENI, F
DEMATTEIS, MA
机构
[1] IST RIC FARMACOL MARIO NEGRI,CONSORZIO MARIO NEGRI SUD,MOLEC NEUROBIOL LAB,I-66030 SANTA MARIA IMBAR,ITALY
[2] UNIV MILAN,FAC PHARM,INST PHARMACOL SCI,I-20122 MILAN,ITALY
关键词
ADENOSINE RECEPTORS; RAT BASOPHILIC LEUKEMIA CELLS; CYCLIC AMP LEVELS; INOSITOL-TRIS-PHOSPHATE PRODUCTION; 5-HYDROXYTRYPTAMINE RELEASE;
D O I
10.1111/j.1476-5381.1992.tb14266.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The presence of adenosine receptors linked to adenylate cyclase activity and their functional role in calcium-evoked 5-hydroxytryptamine (5-HT) release was investigated in rat basophilic leukaemia (RBL) cells, a widely used model for studying the molecular mechanisms responsible for stimulus-secretion coupling. 2 In [H-3]-5-HT-loaded cells triggered to release by the calcium ionophore A23187, a biphasic modulation of 5-HT secretion was induced by adenosine analogues, with inhibition of stimulated release at nM and potentiation at mu-M concentrations, suggesting the presence of adenosine receptor subtypes mediating opposite effects on calcium-dependent release. This was also confirmed by results obtained with other agents interfering with adenosine pharmacology, such as adenosine deaminase and the non-selective A1/A2 antagonist 8-phenyl-theophylline. 3 Similar biphasic dose-response curves were obtained with a variety of adenosine analogues on basal adenylate cyclase activity in RBL cells, with inhibition and stimulation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) production at nM and mu-M concentrations, respectively. The rank order of potency of adenosine analogues for inhibition and stimulation of adenylate cyclase activity and the involvement of G-proteins in modulation of cyclic AMP levels suggested the presence of cyclase-linked A1 high-affinity and A2-like low-affinity adenosine receptor subtypes. However, the atypical antagonism profile displayed by adenosine receptor xanthine antagonists on cyclase stimulation suggested that the A2-like receptor expressed by RBL cells might represent a novel cyclase-coupled A2 receptor subtype. 4 Micromolar concentrations of adenosine analogues could also increase inositol phospholipid hydrolysis and inositol tris-phosphate formation in both unstimulated cells and in cells triggered to release by the calcium ionophore. The stimulation was constant, small and additive to that exerted by the calcium ionophore. 5 It is concluded that RBL cells express both A1 and A2-like adenosine receptors which exert opposite effects on 5-HT release and intracellular cyclic AMP levels. However, besides modulation of cyclic AMP levels, additional transduction pathways, such as modulation of phospholipase C activity, may contribute to the release response evoked by adenosine analogues in this cell-line.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 38 条
[31]   HIGHLY ACTIVATABLE ADENYLATE-CYCLASE IN [2-H-3]ADENINE-PRELABELED VESICLES PREPARED FROM GUINEA-PIG CEREBRAL-CORTEX BY A SIMPLIFIED PROCEDURE [J].
PSYCHOYOS, S ;
DOVE, J ;
STROWBRIDGE, B ;
NUSYNOWITZ, I .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) :1437-1445
[32]   HIGHLY SENSITIVE ADENYLATE CYCLASE ASSAY [J].
SALOMON, Y ;
LONDOS, C ;
RODBELL, M .
ANALYTICAL BIOCHEMISTRY, 1974, 58 (02) :541-548
[33]  
SCOTT RH, 1989, ADENOSINE RECEPTORS, P151
[34]   A1-ADENOSINE AND A2-ADENOSINE RECEPTORS MODULATE ACETYLCHOLINE-RELEASE FROM BRAIN-SLICES [J].
SPIGNOLI, G ;
PEDATA, F ;
PEPEU, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 97 (3-4) :341-342
[35]  
STONE TW, 1989, ADENOSINE RECEPTORS, P87
[36]   ADENOSINE REGULATES VIA 2 DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC-AMP IN CULTURED BRAIN-CELLS [J].
VANCALKER, D ;
MULLER, M ;
HAMPRECHT, B .
JOURNAL OF NEUROCHEMISTRY, 1979, 33 (05) :999-1005
[37]  
WILLIAMS M, 1987, ANNU REV PHARMACOL, V27, P315
[38]   EVALUATION OF THE BINDING OF THE A-1 SELECTIVE ADENOSINE RADIOLIGAND, CYCLOPENTYLADENOSINE (CPA), TO RAT-BRAIN TISSUE [J].
WILLIAMS, M ;
BRAUNWALDER, A ;
ERICKSON, TJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (02) :179-183